AlphaMadera's AlphaVal page classifies Byrna Technologies Inc. as a Cyclical & Capital-Intensive business and values it using Normalized Earnings × Cycle Multiple, then compares the result to the current market price to flag BYRN as undervalued, fairly valued, or overvalued.

What is Byrna Technologies Inc.'s fair value?

Fair value for BYRN comes from a Normalized Earnings × Cycle Multiple model -- the approach AlphaVal selected for this company's Cyclical & Capital-Intensive classification. The live AlphaVal page shows bear, base, and bull scenarios alongside the key assumption behind each.

How does AlphaMadera value BYRN?

AlphaVal routes each company to one of ten valuation archetypes based on its business model. BYRN was classified as Cyclical & Capital-Intensive and is valued using Normalized Earnings × Cycle Multiple, built from BYRN's most recent reported fundamentals.

BYRN - Byrna Technologies Inc.

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $6.50 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Cyclical & Capital-Intensive 80% confidence

Primary model: Normalized Earnings × Cycle Multiple

Valuation Signal Undervalued Strong

Trading 58.1% below fair value

Current Price $3.69

Bear Case $7.20 95.1% upside ($7.20 - $3.69) / $3.69 = 95.1% $0.40 × 18x

Fair Value $8.80 138.5% upside ($8.80 - $3.69) / $3.69 = 138.5% $0.40 × 22x

Bull Case $10.40 181.8% upside ($10.40 - $3.69) / $3.69 = 181.8% $0.40 × 26x

Adjust Assumptions

Cycle P/E Multiple

22.0x

Normalized EPS

0.4$

Key Value Driver

Through-cycle normalized EPS ($0.40)

Terminal Value % of EV

Implied Market Multiple 9.2x

Market is pricing in (growth)

Plain-Language Summary

Using 7-year normalized EPS of $0.40 at a 22x cycle multiple, the base-case value is $8.80 per share. P/TBV cross-check: 1.4x.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (7 analysts) $6.50

Analyst Range $4.50 – $7.50

Divergence from AlphaVal 35%

Warnings

ℹ Wall Street's average price target is $6.50 (from 7 analysts). Our estimate is 35% above the consensus -- consider that gap carefully.

⚠ This stock is 88% below its 52-week high, with weak or declining earnings. That combination often signals real trouble, even though the valuation below is based on other fundamentals.

Key Risks

Standard 10-year DCF produces unreliable terminal values for cyclicals
'Cheap' P/E at cycle peak is the most common value trap — normalize first
Captive finance subsidiaries have different risk profiles from manufacturing